Skip to main content
Top
Published in: World Journal of Surgery 5/2018

01-05-2018 | Original Scientific Report

The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity

Authors: Jae Hyun Park, Dong Hwi Kim, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik, In Su Hong

Published in: World Journal of Surgery | Issue 5/2018

Login to get access

Abstract

Background

The positivity of positron emission tomography (PET) in hepatocellular carcinoma (HCC) correlates with aggressive tumor factors and poor survival. Adequate resection margin size is still a topic of debate. We analyzed the clinical implications of resection margin size in patients with HCC in terms of PET positivity.

Methods

We retrospectively reviewed the medical records of 92 patients who underwent liver resection from March 2012 to October 2015. We investigated prognostic factors for recurrence and survival. We analyzed the correlation of resection margin size and PET positivity. Resection margins were classified as less than 1 cm and more than 1 cm.

Results

Twenty six (31.3%) patients had PET-positive HCC. Multivariate analysis showed PET, satellite nodules, microvessel invasion, and multicentric occurrence were significant prognostic factors for HCC recurrence. Multivariate analysis also showed satellite nodules and microscopic portal vein invasion were significant prognostic factors for overall survival (OS). Resection margin size did not affect disease-free survival (DFS) (p = 0.681) or OS (p = 0.301) in patients with PET-negative HCC, but showed a difference in DFS [<1 cm at 11 months vs. ≥1 cm at 41 months (p = 0.188)] and OS [<1 cm at 28 months vs. ≥1 cm at 48 months (p < 0.001)] in patients with PET-positive HCC.

Conclusions

PET has low sensitivity for HCC. However, it is useful to predict treatment outcomes after liver resection or liver transplantation for HCC. Although the extent of liver resection must be decided based on liver function, a resection margin size >1 cm may improve DFS and OS in patients with PET-positive HCC.
Literature
1.
go back to reference Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379(1245–125):5 Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379(1245–125):5
2.
go back to reference European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943 European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
3.
go back to reference Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC) (2015) 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver 9:267–317 Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC) (2015) 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver 9:267–317
5.
go back to reference Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35:421–430CrossRefPubMed Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35:421–430CrossRefPubMed
6.
go back to reference Kokudo ND, Hasegawa K, Akahane M et al (2015) Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45:123–127CrossRef Kokudo ND, Hasegawa K, Akahane M et al (2015) Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45:123–127CrossRef
7.
go back to reference Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(439–47):4 Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(439–47):4
8.
go back to reference Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22:7–17CrossRefPubMedPubMedCentral Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22:7–17CrossRefPubMedPubMedCentral
9.
go back to reference Poon RTP, Sheung TF, Chung ML et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382CrossRefPubMedPubMedCentral Poon RTP, Sheung TF, Chung ML et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382CrossRefPubMedPubMedCentral
10.
go back to reference Proneth A, Zeman F, Schlitt HJ et al (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21:3096–3107CrossRefPubMed Proneth A, Zeman F, Schlitt HJ et al (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21:3096–3107CrossRefPubMed
11.
go back to reference Bhangui P, Allard MA, Vibert E et al (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: Do both strategies yield similar outcomes? Ann Surg 264:155–163CrossRefPubMed Bhangui P, Allard MA, Vibert E et al (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: Do both strategies yield similar outcomes? Ann Surg 264:155–163CrossRefPubMed
12.
go back to reference Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41CrossRefPubMed Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41CrossRefPubMed
13.
go back to reference Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed
14.
go back to reference Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43CrossRefPubMedPubMedCentral Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43CrossRefPubMedPubMedCentral
15.
go back to reference Park JW, Ji HK, Seok KK et al (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed Park JW, Ji HK, Seok KK et al (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed
16.
go back to reference Kobayashi T, Aikata H, Honda F et al (2016) Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr 40:524–530CrossRefPubMed Kobayashi T, Aikata H, Honda F et al (2016) Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr 40:524–530CrossRefPubMed
17.
go back to reference Asman Y, Evenson AR, Even-Sapir E et al (2015) [18F] fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transp 21:572–580CrossRef Asman Y, Evenson AR, Even-Sapir E et al (2015) [18F] fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transp 21:572–580CrossRef
18.
go back to reference Ahn SG, Jeon TJ, Lee SD et al (2013) A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function Eur. J Surg Oncol 39:964–973CrossRef Ahn SG, Jeon TJ, Lee SD et al (2013) A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function Eur. J Surg Oncol 39:964–973CrossRef
19.
go back to reference Lee HW, Suh K-S (2016) Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 22(309–31):8 Lee HW, Suh K-S (2016) Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 22(309–31):8
20.
go back to reference Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475CrossRefPubMed Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475CrossRefPubMed
21.
go back to reference Makuuchi M (2013) Surgical treatment for HCC—special reference to anatomical resection. Int J Surg 11:S47–S49CrossRefPubMed Makuuchi M (2013) Surgical treatment for HCC—special reference to anatomical resection. Int J Surg 11:S47–S49CrossRefPubMed
22.
go back to reference Castilla-Lièvre MA, Franco D, Gervais P et al (2016) Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 43:852–859CrossRefPubMed Castilla-Lièvre MA, Franco D, Gervais P et al (2016) Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 43:852–859CrossRefPubMed
23.
go back to reference Rodríguez-Perálvarez M, Luong TV, Andreana L et al (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20(325–33):9 Rodríguez-Perálvarez M, Luong TV, Andreana L et al (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20(325–33):9
24.
go back to reference Kim BK, Kang WJ, Kim JK et al (2011) 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787CrossRefPubMed Kim BK, Kang WJ, Kim JK et al (2011) 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787CrossRefPubMed
25.
go back to reference Bailly M, Venel Y, Orain I et al (2016) 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma predicting histology? Clin Nucl Med 41:e126–e129CrossRefPubMed Bailly M, Venel Y, Orain I et al (2016) 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma predicting histology? Clin Nucl Med 41:e126–e129CrossRefPubMed
26.
go back to reference Hyun SH, Eo JS, Lee JW et al (2016) Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with barcelona clinic liver cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging 43:1638–1645CrossRefPubMed Hyun SH, Eo JS, Lee JW et al (2016) Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with barcelona clinic liver cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging 43:1638–1645CrossRefPubMed
27.
go back to reference Min JH, Kim YK, Lim S et al (2015) Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 84:1036–1043CrossRefPubMed Min JH, Kim YK, Lim S et al (2015) Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 84:1036–1043CrossRefPubMed
Metadata
Title
The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity
Authors
Jae Hyun Park
Dong Hwi Kim
Sung Hoon Kim
Moon Young Kim
Soon Koo Baik
In Su Hong
Publication date
01-05-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4275-1

Other articles of this Issue 5/2018

World Journal of Surgery 5/2018 Go to the issue